2025 Q4 -tulosraportti
6 päivää sittenTarjoustasot
NGM - Nordic SME
Määrä
Osto
9 454 782
Myynti
Määrä
108 001
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 300 000 | AVA | AVA | ||
| 10 000 | AVA | AVA | ||
| 290 000 | NON | AVA | ||
| 1 520 000 | NON | AVA | ||
| 372 000 | SWB | AVA |
Ylin
0,013VWAP
Alin
0,007VaihtoMäärä
2 207 969 950
VWAP
Ylin
0,013Alin
0,007VaihtoMäärä
2 207 969 950
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 1.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 20.2. | ||
2025 Q3 -tulosraportti 31.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 9.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·8 t sittenHow high will this end this year, do you think?·7 t sittenI know that too. I was rather wondering if anyone had any thoughts on it now!
·3 t sittenSearched for question (AI: IS Attana's Cell 250 better than other analysis tools? AI: Whether Attana Cell™ 250 is "better" than other models depends on your specific need, but it stands out on one very central point: the ability to perform label-free (label-free) analysis directly on living cells. Attana Attana +1 Here are the most important advantages compared to traditional analysis models: 1. Higher biological relevance Where many traditional methods require purified proteins or synthetic surfaces, Attana Cell™ 250 allows measurements of molecular interactions directly on cells grown on the sensor's surface. This mimics real biological conditions better than many standard models. 2. Unique QCM technology The instrument uses advanced Quartz Crystal Microbalance (QCM) technology. This makes it possible to: Analyze complex samples such as whole blood and serum without prior purification. Measure kinetics (binding and dissociation) in real-time. Obtain data on both affinity and specificity for everything from antibodies to viruses and bacteria. 3. Improvements compared to previous models (e.g., Cell™ 200) Compared to its predecessor and certain competitors, Cell™ 250 offers significant technical upgrades: Integrated autosampler: Provides 3 times higher sample capacity and improved handling. User-friendliness: The system is faster, quieter, and requires less manual calibration. Validated track record: The technology has been used to validate over 100 drug candidates and has, according to Attana, significantly improved the success rate in clinical phase I and II studies. Attana Attana +2 Conclusion: If your work requires insight into how molecules interact with surface receptors on living cells under "in vivo-like" conditions, Attana Cell™ 250 is often superior to purely biochemical models. Question AI: Which companies are competitors of Attana's Cell250 tm? AI: Attana's Cell™ 250 (often referred to as Cell 250tm) is a biosensor based on Quartz Crystal Microbalance (QCM) technology, used for label-free (label-free) real-time analysis of molecular interactions, especially on living cells. Attana Attana +1 Competitors can be divided into direct technological competitors and alternative technological platforms. Direct QCM competitors These companies offer systems based on the same fundamental QCM technology as Attana: Biolin Scientific (AddLife): Produces QSense systems, which are market leaders in QCM with dissipation (QCM-D). AWSensors: Spanish manufacturer of advanced QCM solutions for biosensing and surface analysis. MicroVacuum: Offers the QCM-I system, which is a modular and affordable alternative to complex biosensor measurements. 3T Analytik: German manufacturer of QCM systems aimed at life science research. Gamry Instruments: Known for integrating QCM with electrochemical measurements (eQCM). Data Insights Market Data Insights Market +4 Alternative technological competitors Many laboratories choose other label-free technologies for the same types of analyses that Attana Cell™ 250 performs: Surface Plasmon Resonance (SPR): The most widespread technology for interaction analysis. Here, the biggest competitors are Cytiva (Biacore systems) and Bruker (Sierra SPR platforms). Bio-Layer Interferometry (BLI): Sartorius (Octet systems) is a major competitor in fast, label-free kinetic measurement. Impedance-based systems: Agilent Technologies offers the xCELLigence platform, which, like Attana, can monitor living cells in real-time without the use of labeling. National Institutes of Health (.gov) National Institutes of Health (.gov) Why Attana differs According to Attana itself, they are unique in having cells integrated as the sensor surface itself, which makes it possible to mimic conditions in the human body (in vivo-like results) more precisely than traditional synthetic sensor surfaces. Remember that it is AI and there may be errors. Attana has a market capitalization of approx. 15 million SEK. For a large medium-sized biotech company, they would not be able to see an acquisition of Attana in their financial statements.
3 päivää sitten3 päivää sittenI´m back here, after many years! Just/only 100,000 pcs. and about 95,00 €! Now just sit & wait for better times!- ·20.2.Exciting little one. There are indeed some very large acquisitions in this. And the latest news was good.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
6 päivää sittenUutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·8 t sittenHow high will this end this year, do you think?·7 t sittenI know that too. I was rather wondering if anyone had any thoughts on it now!·3 t sittenSearched for question (AI: IS Attana's Cell 250 better than other analysis tools? AI: Whether Attana Cell™ 250 is "better" than other models depends on your specific need, but it stands out on one very central point: the ability to perform label-free (label-free) analysis directly on living cells. Attana Attana +1 Here are the most important advantages compared to traditional analysis models: 1. Higher biological relevance Where many traditional methods require purified proteins or synthetic surfaces, Attana Cell™ 250 allows measurements of molecular interactions directly on cells grown on the sensor's surface. This mimics real biological conditions better than many standard models. 2. Unique QCM technology The instrument uses advanced Quartz Crystal Microbalance (QCM) technology. This makes it possible to: Analyze complex samples such as whole blood and serum without prior purification. Measure kinetics (binding and dissociation) in real-time. Obtain data on both affinity and specificity for everything from antibodies to viruses and bacteria. 3. Improvements compared to previous models (e.g., Cell™ 200) Compared to its predecessor and certain competitors, Cell™ 250 offers significant technical upgrades: Integrated autosampler: Provides 3 times higher sample capacity and improved handling. User-friendliness: The system is faster, quieter, and requires less manual calibration. Validated track record: The technology has been used to validate over 100 drug candidates and has, according to Attana, significantly improved the success rate in clinical phase I and II studies. Attana Attana +2 Conclusion: If your work requires insight into how molecules interact with surface receptors on living cells under "in vivo-like" conditions, Attana Cell™ 250 is often superior to purely biochemical models. Question AI: Which companies are competitors of Attana's Cell250 tm? AI: Attana's Cell™ 250 (often referred to as Cell 250tm) is a biosensor based on Quartz Crystal Microbalance (QCM) technology, used for label-free (label-free) real-time analysis of molecular interactions, especially on living cells. Attana Attana +1 Competitors can be divided into direct technological competitors and alternative technological platforms. Direct QCM competitors These companies offer systems based on the same fundamental QCM technology as Attana: Biolin Scientific (AddLife): Produces QSense systems, which are market leaders in QCM with dissipation (QCM-D). AWSensors: Spanish manufacturer of advanced QCM solutions for biosensing and surface analysis. MicroVacuum: Offers the QCM-I system, which is a modular and affordable alternative to complex biosensor measurements. 3T Analytik: German manufacturer of QCM systems aimed at life science research. Gamry Instruments: Known for integrating QCM with electrochemical measurements (eQCM). Data Insights Market Data Insights Market +4 Alternative technological competitors Many laboratories choose other label-free technologies for the same types of analyses that Attana Cell™ 250 performs: Surface Plasmon Resonance (SPR): The most widespread technology for interaction analysis. Here, the biggest competitors are Cytiva (Biacore systems) and Bruker (Sierra SPR platforms). Bio-Layer Interferometry (BLI): Sartorius (Octet systems) is a major competitor in fast, label-free kinetic measurement. Impedance-based systems: Agilent Technologies offers the xCELLigence platform, which, like Attana, can monitor living cells in real-time without the use of labeling. National Institutes of Health (.gov) National Institutes of Health (.gov) Why Attana differs According to Attana itself, they are unique in having cells integrated as the sensor surface itself, which makes it possible to mimic conditions in the human body (in vivo-like results) more precisely than traditional synthetic sensor surfaces. Remember that it is AI and there may be errors. Attana has a market capitalization of approx. 15 million SEK. For a large medium-sized biotech company, they would not be able to see an acquisition of Attana in their financial statements.
- 3 päivää sitten3 päivää sittenI´m back here, after many years! Just/only 100,000 pcs. and about 95,00 €! Now just sit & wait for better times!
- ·20.2.Exciting little one. There are indeed some very large acquisitions in this. And the latest news was good.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
NGM - Nordic SME
Määrä
Osto
9 454 782
Myynti
Määrä
108 001
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 300 000 | AVA | AVA | ||
| 10 000 | AVA | AVA | ||
| 290 000 | NON | AVA | ||
| 1 520 000 | NON | AVA | ||
| 372 000 | SWB | AVA |
Ylin
0,013VWAP
Alin
0,007VaihtoMäärä
2 207 969 950
VWAP
Ylin
0,013Alin
0,007VaihtoMäärä
2 207 969 950
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 1.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 20.2. | ||
2025 Q3 -tulosraportti 31.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 9.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
2025 Q4 -tulosraportti
6 päivää sittenUutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 1.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 20.2. | ||
2025 Q3 -tulosraportti 31.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 9.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·8 t sittenHow high will this end this year, do you think?·7 t sittenI know that too. I was rather wondering if anyone had any thoughts on it now!·3 t sittenSearched for question (AI: IS Attana's Cell 250 better than other analysis tools? AI: Whether Attana Cell™ 250 is "better" than other models depends on your specific need, but it stands out on one very central point: the ability to perform label-free (label-free) analysis directly on living cells. Attana Attana +1 Here are the most important advantages compared to traditional analysis models: 1. Higher biological relevance Where many traditional methods require purified proteins or synthetic surfaces, Attana Cell™ 250 allows measurements of molecular interactions directly on cells grown on the sensor's surface. This mimics real biological conditions better than many standard models. 2. Unique QCM technology The instrument uses advanced Quartz Crystal Microbalance (QCM) technology. This makes it possible to: Analyze complex samples such as whole blood and serum without prior purification. Measure kinetics (binding and dissociation) in real-time. Obtain data on both affinity and specificity for everything from antibodies to viruses and bacteria. 3. Improvements compared to previous models (e.g., Cell™ 200) Compared to its predecessor and certain competitors, Cell™ 250 offers significant technical upgrades: Integrated autosampler: Provides 3 times higher sample capacity and improved handling. User-friendliness: The system is faster, quieter, and requires less manual calibration. Validated track record: The technology has been used to validate over 100 drug candidates and has, according to Attana, significantly improved the success rate in clinical phase I and II studies. Attana Attana +2 Conclusion: If your work requires insight into how molecules interact with surface receptors on living cells under "in vivo-like" conditions, Attana Cell™ 250 is often superior to purely biochemical models. Question AI: Which companies are competitors of Attana's Cell250 tm? AI: Attana's Cell™ 250 (often referred to as Cell 250tm) is a biosensor based on Quartz Crystal Microbalance (QCM) technology, used for label-free (label-free) real-time analysis of molecular interactions, especially on living cells. Attana Attana +1 Competitors can be divided into direct technological competitors and alternative technological platforms. Direct QCM competitors These companies offer systems based on the same fundamental QCM technology as Attana: Biolin Scientific (AddLife): Produces QSense systems, which are market leaders in QCM with dissipation (QCM-D). AWSensors: Spanish manufacturer of advanced QCM solutions for biosensing and surface analysis. MicroVacuum: Offers the QCM-I system, which is a modular and affordable alternative to complex biosensor measurements. 3T Analytik: German manufacturer of QCM systems aimed at life science research. Gamry Instruments: Known for integrating QCM with electrochemical measurements (eQCM). Data Insights Market Data Insights Market +4 Alternative technological competitors Many laboratories choose other label-free technologies for the same types of analyses that Attana Cell™ 250 performs: Surface Plasmon Resonance (SPR): The most widespread technology for interaction analysis. Here, the biggest competitors are Cytiva (Biacore systems) and Bruker (Sierra SPR platforms). Bio-Layer Interferometry (BLI): Sartorius (Octet systems) is a major competitor in fast, label-free kinetic measurement. Impedance-based systems: Agilent Technologies offers the xCELLigence platform, which, like Attana, can monitor living cells in real-time without the use of labeling. National Institutes of Health (.gov) National Institutes of Health (.gov) Why Attana differs According to Attana itself, they are unique in having cells integrated as the sensor surface itself, which makes it possible to mimic conditions in the human body (in vivo-like results) more precisely than traditional synthetic sensor surfaces. Remember that it is AI and there may be errors. Attana has a market capitalization of approx. 15 million SEK. For a large medium-sized biotech company, they would not be able to see an acquisition of Attana in their financial statements.
- 3 päivää sitten3 päivää sittenI´m back here, after many years! Just/only 100,000 pcs. and about 95,00 €! Now just sit & wait for better times!
- ·20.2.Exciting little one. There are indeed some very large acquisitions in this. And the latest news was good.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
NGM - Nordic SME
Määrä
Osto
9 454 782
Myynti
Määrä
108 001
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 300 000 | AVA | AVA | ||
| 10 000 | AVA | AVA | ||
| 290 000 | NON | AVA | ||
| 1 520 000 | NON | AVA | ||
| 372 000 | SWB | AVA |
Ylin
0,013VWAP
Alin
0,007VaihtoMäärä
2 207 969 950
VWAP
Ylin
0,013Alin
0,007VaihtoMäärä
2 207 969 950
Välittäjätilasto
Dataa ei löytynyt